BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36200034)

  • 1. Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (
    Fournier N; Fabre A
    Intractable Rare Dis Res; 2022 Aug; 11(3):113-119. PubMed ID: 36200034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.
    Ravenscroft G; Pannell S; O'Grady G; Ong R; Ee HC; Faiz F; Marns L; Goel H; Kumarasinghe P; Sollis E; Sivadorai P; Wilson M; Magoffin A; Nightingale S; Freckmann ML; Kirk EP; Sachdev R; Lemberg DA; Delatycki MB; Kamm MA; Basnayake C; Lamont PJ; Amor DJ; Jones K; Schilperoort J; Davis MR; Laing NG
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13371. PubMed ID: 29781137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome.
    Geraghty RM; Orr S; Olinger E; Neatu R; Barroso-Gil M; Mabillard H; Consortium GER; Wilson I; Sayer JA
    J Rare Dis (Berlin); 2023; 2(1):9. PubMed ID: 37288276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing.
    Dong W; Baldwin C; Choi J; Milunsky JM; Zhang J; Bilguvar K; Lifton RP; Milunsky A
    Clin Genet; 2019 Nov; 96(5):473-477. PubMed ID: 31389005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous loss of function variants in MYL9 in a child with megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Kandler JL; Sklirou E; Woerner A; Walsh L; Cox E; Xue Y
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1516. PubMed ID: 33031641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Intestinal Pseudo-obstruction in the Era of Genetic Sequencing.
    Gamboa HE; Sood M
    Curr Gastroenterol Rep; 2019 Dec; 21(12):70. PubMed ID: 31848803
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hahn JW; Moon SY; Kim MS; Woo MH; Sohn MJ; Kim HY; Seong MW; Park SS; Park SH; Moon JS; Ko JS
    J Neurogastroenterol Motil; 2022 Jan; 28(1):104-110. PubMed ID: 34980693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.
    Moreno CA; Metze K; Lomazi EA; Bertola DR; Barbosa RH; Cosentino V; Sobreira N; Cavalcanti DP
    Am J Med Genet A; 2016 Nov; 170(11):2965-2974. PubMed ID: 27481187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Moreno CA; Sobreira N; Pugh E; Zhang P; Steel G; Torres FR; Cavalcanti DP
    Eur J Hum Genet; 2018 May; 26(5):669-675. PubMed ID: 29453416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice.
    Halim D; Wilson MP; Oliver D; Brosens E; Verheij JB; Han Y; Nanda V; Lyu Q; Doukas M; Stoop H; Brouwer RW; van IJcken WF; Slivano OJ; Burns AJ; Christie CK; de Mesy Bentley KL; Brooks AS; Tibboel D; Xu S; Jin ZG; Djuwantono T; Yan W; Alves MM; Hofstra RM; Miano JM
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2739-E2747. PubMed ID: 28292896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
    Tuzovic L; Tang S; Miller RS; Rohena L; Shahmirzadi L; Gonzalez K; Li X; LeDuc CA; Guo J; Wilson A; Mills A; Glassberg K; Rotterdam H; Sepulveda AR; Zeng W; Chung WK; Anyane-Yeboa K
    Fetal Diagn Ther; 2015; 38(4):296-306. PubMed ID: 25998219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological, Ultrastructural, and Immunohistochemical Findings in
    Kapur RP
    Pediatr Dev Pathol; 2023; 26(1):39-51. PubMed ID: 36571289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Gauthier J; Ouled Amar Bencheikh B; Hamdan FF; Harrison SM; Baker LA; Couture F; Thiffault I; Ouazzani R; Samuels ME; Mitchell GA; Rouleau GA; Michaud JL; Soucy JF
    Eur J Hum Genet; 2015 Sep; 23(9):1266-8. PubMed ID: 25407000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kindlin-2 deficiency induces fatal intestinal obstruction in mice.
    He X; Song J; Cai Z; Chi X; Wang Z; Yang D; Xie S; Zhou J; Fu Y; Li W; Kong W; Zhan J; Zhang H
    Theranostics; 2020; 10(14):6182-6200. PubMed ID: 32483447
    [No Abstract]   [Full Text] [Related]  

  • 15. Visceral myopathy diagnosed by a de novo
    Xiong X; Li J; Liu C; Xu F
    Transl Pediatr; 2021 Mar; 10(3):679-685. PubMed ID: 33880338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long Filamin-A isoform is required for intestinal development and motility: implications for chronic intestinal pseudo-obstruction.
    Zada A; Zhao Y; Halim D; Windster J; van der Linde HC; Glodener J; Overkleeft S; de Graaf BM; Verdijk RM; Brooks AS; Shepherd I; Gao Y; Burns AJ; Hofstra RMW; Alves MM
    Hum Mol Genet; 2023 Jan; 32(1):151-160. PubMed ID: 35981053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction.
    Bonora E; Bianco F; Cordeddu L; Bamshad M; Francescatto L; Dowless D; Stanghellini V; Cogliandro RF; Lindberg G; Mungan Z; Cefle K; Ozcelik T; Palanduz S; Ozturk S; Gedikbasi A; Gori A; Pippucci T; Graziano C; Volta U; Caio G; Barbara G; D'Amato M; Seri M; Katsanis N; Romeo G; De Giorgio R
    Gastroenterology; 2015 Apr; 148(4):771-782.e11. PubMed ID: 25575569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
    Matera I; Rusmini M; Guo Y; Lerone M; Li J; Zhang J; Di Duca M; Nozza P; Mosconi M; Pini Prato A; Martucciello G; Barabino A; Morandi F; De Giorgio R; Stanghellini V; Ravazzolo R; Devoto M; Hakonarson H; Ceccherini I
    Eur J Hum Genet; 2016 Aug; 24(8):1211-5. PubMed ID: 26813947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Pathological Features of Severe Gut Dysmotility.
    Bianco F; Bonora E; Lattanzio G; Clavenzani P; Guarino M; Mazzoni M; Baldassarro VA; Lorenzini L; Caio G; Stanghellini V; Sternini C; Farrugia G; Giardino L; Calzà L; De Giorgio R
    Adv Exp Med Biol; 2022; 1383():9-17. PubMed ID: 36587142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.
    Matera I; Bordo D; Di Duca M; Lerone M; Santamaria G; Pongiglione M; Lezo A; Diamanti A; Spagnuolo MI; Pini Prato A; Alberti D; Mattioli G; Gandullia P; Ceccherini I
    Clin Genet; 2021 Mar; 99(3):430-436. PubMed ID: 33294969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.